Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis

The Lancet Neurology in conversation with
16/07/2025 8 min
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis

Listen "Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis"

Descargar episodio

Episode Synopsis

In this episode, host Laura Hart chats with Professor Amit Bar-Or (University of Pennsylvania) about the potential of the BTK inhibitor fenebrutinib in treating relapsing multiple sclerosis, highlighting future challenges in MS research.Read the full article:https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00174-7/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laneurContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

More episodes of the podcast The Lancet Neurology in conversation with

Ian McKeith on dementia with dementia with Lewy bodies 12/11/2025
Ask Nordestgaard on long-term stroke risk in women 15/10/2025
Shiv Saidha on recent updates in the diagnosis of multiple sclerosis 17/09/2025
Michael Rafii on Down syndrome-related Alzheimer’s disease 13/08/2025
Marte-Helene Bjørk on reproductive risks in people with epilepsy 17/06/2025
Geoff Manley on a new classification system for traumatic brain injury 20/05/2025
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy 16/04/2025
Marialuisa Gandolfi on the management of chronic pain in Parkinson's disease 19/03/2025
Michael Tymianski on neuroprotection in stroke 19/02/2025
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia 22/01/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA